Cite
HARVARD Citation
Chiritescu, G. et al. (n.d.). O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results. Annals of oncology. p. . [Online].